Compare PKOH & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKOH | KMDA |
|---|---|---|
| Founded | 1907 | 1990 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.0M | 460.3M |
| IPO Year | 1994 | 2013 |
| Metric | PKOH | KMDA |
|---|---|---|
| Price | $39.06 | $7.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $37.00 | $14.00 |
| AVG Volume (30 Days) | ★ 61.1K | 36.6K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | 1.69% | ★ 3.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $1,599,100,000.00 | N/A |
| Revenue This Year | $7.87 | $13.94 |
| Revenue Next Year | $3.42 | $9.84 |
| P/E Ratio | $67.16 | ★ $24.59 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.52 | $6.50 |
| 52 Week High | $38.44 | $9.35 |
| Indicator | PKOH | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 75.71 | 39.92 |
| Support Level | $19.32 | $6.57 |
| Resistance Level | N/A | $7.44 |
| Average True Range (ATR) | 1.37 | 0.16 |
| MACD | 0.28 | 0.01 |
| Stochastic Oscillator | 89.77 | 50.00 |
Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.